Physiologic hyperinsulinemia enhances counterregulatory hormone responses to hypoglycemia in IDDM

Maris R. Davis, Michael Mellman, Harry Shamoon

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

We evaluated the effect of physiologic hyperinsulinemia (plasma insulin 329 ± 62 vs 687 ± 62 pmol/L) on counterregulatory hormone responses in 8 IDDM subjects studied during a 2-hour hypoglycemic clamp study with an equivalent degree of hypoglycemia (plasma glucose 3.1 ± 0.1 and 3.0 ± 0.1 mmol/L, respectively). Plasma epinephrine levels were increased by 71% during the last 60 minutes of hypoglycemia in the high insulin study (840 ± 180 vs 1440 ± 310 pmol/L, respectively p=0.006). In addition, plasma cortisol and norepinephrine were also increased in the high insulin study (by 19% and 24% respectively, p<0.01, for both). Plasma growth hormone and glucagon concentrations were not altered by high dose insulin infusion. In spite of increased epinephrine secretion, the glucose infusion rate required to maintain glucose was 2-fold greater in the high insulin study, and there was greater suppression of lipolysis in that group. We conclude that hyperinsulinemia may enhance counterregulatory hormone secretion in IDDM.

Original languageEnglish (US)
Pages (from-to)1383-1385
Number of pages3
JournalJournal of Clinical Endocrinology and Metabolism
Volume76
Issue number5
StatePublished - May 1993

Fingerprint

Hyperinsulinism
Type 1 Diabetes Mellitus
Hypoglycemia
Hormones
Insulin
Plasmas
Glucose
Epinephrine
Lipolysis
Clamping devices
Glucagon
Hypoglycemic Agents
Growth Hormone
Hydrocortisone
Norepinephrine

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Physiologic hyperinsulinemia enhances counterregulatory hormone responses to hypoglycemia in IDDM. / Davis, Maris R.; Mellman, Michael; Shamoon, Harry.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 76, No. 5, 05.1993, p. 1383-1385.

Research output: Contribution to journalArticle

@article{4bafbb4f1fc241349101087a5349c91f,
title = "Physiologic hyperinsulinemia enhances counterregulatory hormone responses to hypoglycemia in IDDM",
abstract = "We evaluated the effect of physiologic hyperinsulinemia (plasma insulin 329 ± 62 vs 687 ± 62 pmol/L) on counterregulatory hormone responses in 8 IDDM subjects studied during a 2-hour hypoglycemic clamp study with an equivalent degree of hypoglycemia (plasma glucose 3.1 ± 0.1 and 3.0 ± 0.1 mmol/L, respectively). Plasma epinephrine levels were increased by 71{\%} during the last 60 minutes of hypoglycemia in the high insulin study (840 ± 180 vs 1440 ± 310 pmol/L, respectively p=0.006). In addition, plasma cortisol and norepinephrine were also increased in the high insulin study (by 19{\%} and 24{\%} respectively, p<0.01, for both). Plasma growth hormone and glucagon concentrations were not altered by high dose insulin infusion. In spite of increased epinephrine secretion, the glucose infusion rate required to maintain glucose was 2-fold greater in the high insulin study, and there was greater suppression of lipolysis in that group. We conclude that hyperinsulinemia may enhance counterregulatory hormone secretion in IDDM.",
author = "Davis, {Maris R.} and Michael Mellman and Harry Shamoon",
year = "1993",
month = "5",
language = "English (US)",
volume = "76",
pages = "1383--1385",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Physiologic hyperinsulinemia enhances counterregulatory hormone responses to hypoglycemia in IDDM

AU - Davis, Maris R.

AU - Mellman, Michael

AU - Shamoon, Harry

PY - 1993/5

Y1 - 1993/5

N2 - We evaluated the effect of physiologic hyperinsulinemia (plasma insulin 329 ± 62 vs 687 ± 62 pmol/L) on counterregulatory hormone responses in 8 IDDM subjects studied during a 2-hour hypoglycemic clamp study with an equivalent degree of hypoglycemia (plasma glucose 3.1 ± 0.1 and 3.0 ± 0.1 mmol/L, respectively). Plasma epinephrine levels were increased by 71% during the last 60 minutes of hypoglycemia in the high insulin study (840 ± 180 vs 1440 ± 310 pmol/L, respectively p=0.006). In addition, plasma cortisol and norepinephrine were also increased in the high insulin study (by 19% and 24% respectively, p<0.01, for both). Plasma growth hormone and glucagon concentrations were not altered by high dose insulin infusion. In spite of increased epinephrine secretion, the glucose infusion rate required to maintain glucose was 2-fold greater in the high insulin study, and there was greater suppression of lipolysis in that group. We conclude that hyperinsulinemia may enhance counterregulatory hormone secretion in IDDM.

AB - We evaluated the effect of physiologic hyperinsulinemia (plasma insulin 329 ± 62 vs 687 ± 62 pmol/L) on counterregulatory hormone responses in 8 IDDM subjects studied during a 2-hour hypoglycemic clamp study with an equivalent degree of hypoglycemia (plasma glucose 3.1 ± 0.1 and 3.0 ± 0.1 mmol/L, respectively). Plasma epinephrine levels were increased by 71% during the last 60 minutes of hypoglycemia in the high insulin study (840 ± 180 vs 1440 ± 310 pmol/L, respectively p=0.006). In addition, plasma cortisol and norepinephrine were also increased in the high insulin study (by 19% and 24% respectively, p<0.01, for both). Plasma growth hormone and glucagon concentrations were not altered by high dose insulin infusion. In spite of increased epinephrine secretion, the glucose infusion rate required to maintain glucose was 2-fold greater in the high insulin study, and there was greater suppression of lipolysis in that group. We conclude that hyperinsulinemia may enhance counterregulatory hormone secretion in IDDM.

UR - http://www.scopus.com/inward/record.url?scp=0027212159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027212159&partnerID=8YFLogxK

M3 - Article

C2 - 8496333

AN - SCOPUS:0027212159

VL - 76

SP - 1383

EP - 1385

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -